Tisdag 17 Mars | 12:09:17 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-11-04 08:10 Kvartalsrapport 2026-Q3
2026-07-21 08:10 Kvartalsrapport 2026-Q2
2026-05-08 N/A X-dag ordinarie utdelning ASKER 0.39 SEK
2026-05-07 N/A Årsstämma
2026-05-06 08:10 Kvartalsrapport 2026-Q1
2026-02-10 - Bokslutskommuniké 2025
2025-12-09 - Extra Bolagsstämma 2026
2025-11-06 - Kvartalsrapport 2025-Q3
2025-07-22 - Kvartalsrapport 2025-Q2
2025-05-13 - Kvartalsrapport 2025-Q1

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriLäkemedel & Handel
Asker Healthcare är en serieförvärvare inom medicintekniska produkter och tjänster. Koncernen består av ett antal företag med verksamhet i flera länder i Europa. Genom bolagets tillväxtplattform förvärvar de kontinuerligt medtech-företag på den europeiska marknaden, med målet att förbättra vårdresultat och stödja hälso- och sjukvårdssektorn. Bolaget har sitt huvudkontor i Danderyd.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-01-27 10:00:00

Asker Healthcare Group will publish its Year-End Report for 2025 on 10 February, at 08:10 CET.

Asker invites investors, analysts and media to a webcast presentation on the same day at 10:00 CET. Asker's CEO Johan Falk and CFO Thomas Moss will present and comment on the report, followed by a Q&A session.

You will find the webcast link via Year-End Report 2025

To participate via phone and ask questions, please register via Call Access.

The presentation materials will be available on www.asker.com after the meeting, where you can also watch and listen to the presentation on demand.

For further information, please contact:
Thomas Moss, CFO and Head of Investor Relations
Phone: +46 70 219 79 05
E-mail: ir@asker.com

Emma Rheborg, Head of Communication
Phone: +46 73 313 62 17
E-mail: emma.rheborg@asker.com

Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group - driving progress in the healthcare sector. The group has more than 4 500 employees in 19 countries and revenues amounting to SEK 16 billion.